Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-08-20

Clinical Trial Update: Improving the Reproductive Outcome of Poor Quality Ova by Injection of Autologous Somatic Mitochondria [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating autologous somatic mitochondrial transfer to improve reproductive outcomes in women with low ovarian reserve/poor quality oocytes h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Autologous somatic mitochondrial transfer

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Low Ovarian Reserve, Poor Quality Oocytes | Phase 1, Phase 2 | Status: WITHDRAWN